27 March 2024 true No description of principal activity Taxfiler 2024.6 15598601business:PrivateLimitedCompanyLtd2024-03-272025-03-31 155986012024-03-26 15598601business:EntityNoLongerTradingButTradedInPast2024-03-272025-03-31 155986012024-03-272025-03-31 15598601business:AuditExempt-NoAccountantsReport2024-03-272025-03-31 15598601business:FilletedAccounts2024-03-272025-03-31 155986012025-03-31 15598601business:Director12024-03-272025-03-31 15598601business:RegisteredOffice2024-03-272025-03-31 15598601core:ShareCapitalcore:PreviouslyStatedAmount2025-03-31 15598601core:PreviouslyStatedAmount2025-03-31 15598601business:SmallEntities2024-03-272025-03-31 15598601countries:EnglandWales2024-03-272025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 15598601 (England and Wales)
Paris Pharma Limited Unaudited accounts for the period from 27 March 2024 to 31 March 2025
Paris Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Paris Pharma Limited Company Information for the period from 27 March 2024 to 31 March 2025
Director
Parastoo Fakouri
Company Number
15598601 (England and Wales)
Registered Office
45 Holland Road London London NW10 5AT England
Accountants
Certax Accounting (Fitzrovia) Limited 85 Tottenham Court Road London W1T 4TQ
- 3 -
Paris Pharma Limited Statement of financial position as at 31 March 2025
2025 
Notes
£ 
Current assets
Cash at bank and in hand
100 
Net current assets
100 
Net assets
100 
Capital and reserves
Called up share capital
100 
Shareholders' funds
100 
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 22 December 2025 and were signed on its behalf by
Parastoo Fakouri Director Company Registration No. 15598601
- 4 -
Paris Pharma Limited Notes to the Accounts for the period from 27 March 2024 to 31 March 2025
1
Statutory information
Paris Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15598601. The registered office is 45 Holland Road, London, London, NW10 5AT, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the period the average number of employees was 0.
- 5 -